M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery

Completed

Conditions: Lung Cancer

Interventions: Behavioral: Interactive Voice Response (IVR)
Behavioral: Questionnaire

First Posted Date: 2007-07-16

Last Posted Date: 2011-11-08

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 127

Registration Number: NCT00501319

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Physical Activity After Endometrial Cancer

Active, not recruiting

Conditions: Endometrial Cancer

Interventions: Behavioral: Personalized Exercise Program
Behavioral: Questionnaire
Behavioral: Suggested Exercise Program

First Posted Date: 2007-07-16

Last Posted Date: 2020-12-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 326

Registration Number: NCT00501761

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Completed

Conditions: Multiple Endocrine Neoplasia

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-16

Last Posted Date: 2020-11-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 133

Registration Number: NCT00501449

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Pain Quantification and Pain Management in Interventional Radiology (IR)

Completed

Conditions: Pain

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-13

Last Posted Date: 2012-08-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 374

Registration Number: NCT00500942

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Cardiomyopathy Tissue Bank in a Cancer Population

Conditions: Heart Disease

Interventions: Procedure: Blood Sample

First Posted Date: 2007-07-13

Last Posted Date: 2020-01-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1000

Registration Number: NCT00500734

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Treatment of Tumors of the Choroid Plexus Epithelium

Phase 3

Terminated

Conditions: Choroid Plexus Tumors

Interventions: Drug: Carboplatin
Drug: Cyclophosphamide
Drug: Etoposide
Drug: Vincristine
Radiation: Radiation Therapy

First Posted Date: 2007-07-13

Last Posted Date: 2020-02-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00500890

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: Doxil
Drug: Gemcitabine
Drug: Velcade

First Posted Date: 2007-07-12

Last Posted Date: 2013-02-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 134

Registration Number: NCT00500422

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Phase 4

Completed

Conditions: Hematological Malignancies

Interventions: Drug: Ribavirin

First Posted Date: 2007-07-12

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 51

Registration Number: NCT00500578

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Phase 2

Terminated

Conditions: Leukemia

Interventions: Drug: Imatinib Mesylate
Drug: Fludarabine (Fludara)
Drug: Busulfan
Drug: Antithymocyte Globulin (ATG)
Drug: Tacrolimus
Drug: Methotrexate
Procedure: Donor lymphocyte infusion (DLI)
Procedure: Stem Cell Transplant

First Posted Date: 2007-07-12

Last Posted Date: 2012-04-23

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 42

Registration Number: NCT00499889

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: CT Scans
Procedure: Implanted markers
Radiation: Radiation Treatment (RT)

First Posted Date: 2007-07-12

Last Posted Date: 2013-02-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 10

Registration Number: NCT00500513

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy